Safety Alerts Saves Lives
Safety Alerts  
Home Privacy About Us Contact Us Change Preferences
May 28, 2003

Alpharma Purepac Has Recalled Bisoprolol Fumarate and Hydrochlorothiazide Tablets

(SafetyAlerts) - The Food and Drug Administration (FDA) released the following information.

a) Bisoprolol Fumarate and Hydrochlorothiazide Tablets,
2.5 mg/6.25mg, bottles of 100, Rx only. Recall # D-255-3;
b) Bisoprolol Fumarate and Hydrochlorothiazide Tablets,
5 mg/6.25mg, bottles of 100, Rx only. Recall # D-256-3;
c) Bisoprolol Fumarate and Hydrochlorothiazide Tablets,
10mg/6.25mg. bottles of 30, Rx only. Recall # D-257-3.

a) Lot No. 306M11 Exp Date 1/03; 460F21 Exp Date 10/03;
481C11 Exp Date 9/03; 575H11 Exp Date 5/03;
576H11 Exp Date 5/03; 870D21 Exp Date 5/03;
871D21 Exp Date 11/03; 872D21 Exp Date 11/03;
966E11 Exp Date 6/03; 967E11 Exp Date 6/03;
b) Lot No. 307M11 Exp Date 1/04; 308M11 Exp Date 1/04;
309M11 Exp Date 1/04; 361B11 Exp Date 3/03;
362B11 Exp Date 3/03; 482C11 Exp Date 3/03;
483C11 Exp Date 3/03; 577H11 Exp Date 10/03;
578H11 Exp Date 10/03; 873D21 Exp Date 5/04;
874D21 Exp Date 5/04; 875D21 Exp Date 5/04;
876D21 Exp Date 5/04; 968E11 Exp Date 6/03;
969E11 Exp Date 8/03;
c) Lot No. 310M11 Exp. Date 1/04; 363B11 Exp. Date 3/03;
579H11 Exp. Date 9/03; 580H11 Exp. Date 9/03;
877D21 Exp. Date 5/04; 878D21 Exp. Date 5/04;
879D21 Exp. Date 5/04; 970E11 Exp. Date 6/03.

Alpharma Purepac, Elizabeth, NJ, by letter dated March 20, 2003 and sent via certified mail on March 21, 2003. Firm initiated recall is ongoing.

Impurity failure; product failed to meet the Bisoprolol Fumarate unknown impurity specification.

756,230 bottles.


Selected Recent Recalls

Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.


The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.